Sitemap
Posts
- Cromos Pharma profiled in The Top 20 Contract Research Organizations in Europe in Research and Markets (26.03.2008)
- Annual ASCO meeting (03.06.2010)
- CEO, Dr. Vlad Bogin collaborates on a scientific publication describing new gene responsible for heart damage in diabetics (11.06.2010)
- 45 DIA Annual Meeting (20.06.2010)
- Cromos Pharma participated in Rodman & Renshaw Annual Healthcare conference (09.09.2010)
- CEO, Dr. Vlad Bogin collaborates on a scientific publication describing stem cell treatment of a spinal cord injury patient (09.11.2010)
- CP will be attending JP Morgan Healthcare conference in San Francisco, CA. (09.01.2011)
- 47 DIA Annual Meeting (14.03.2011)
- ASCO Annual Meeting 2011 (29.03.2011)
- The 2011 European Multidisciplinary Cancer Congress (14.07.2011)
- 17th Annual International Partnering Conference BIO-Europe 2011 (27.09.2011)
- Cromos Pharma's CEO JP Morgan Healthcare Conferece on 9-12 January 2012 (05.01.2012)
- Meet Cromos Pharma team at ASCO Annual Meeting 2012 (19.03.2012)
- Cromos™ Pharma will participate in 2012 BIO International Convention in Boston, MA, USA on 18-21 June 2012 (14.06.2012)
- Cromos™ Pharma CEO Dr. Bogin will attend UBS Global Healthcare Conference in New York, USA on 19-20 September 2012 (05.09.2012)
- Cromos™ Pharma team will attend Partnership in Clinical Trials Conference in Hamburg, Germany on 07-08 November 2012 (24.10.2012)
- Cromos™ Pharma CEO Dr. Bogin will participate in 31st Annual J.P. Morgan Healthcare Conference in San Francisco, USA on 7-9 January 2013 (27.12.2012)
- Cromos™ Pharma helps Regen Biopharma in filing of an Investigational New Drug (IND) application with the FDA (06.02.2013)
- Cromos™ Pharma's team will attend 4th Annual Outsourcing in Clinical Trials East Coast conference in Philadelphia, USA on 19-20 March 2013 (11.03.2013)
- Cromos™ Pharma's team will attend 4th Annual Outsourcing in Clinical Trials East Coast conference in Philadelphia, USA on 19-20 March 2013 (11.03.2013)
- Video of Cromos™ Pharma's CEO participation in round table on our charitable work under the auspices of nonprofit organization, Stand Up To Cancer (19.03.2013)
- Cromos™ Pharma's team will attend 22nd Annual Partnerships in Clinical Trials Conference in Orlando, USA on 21-24 April 2013 (28.03.2013)
- Cromos™ Pharma CEO Dr. Bogin will be presenting at MAGI Clinical Research Conference in Boston, USA that will take place on 5-8 May 2013 (08.04.2013)
- Clinical Research (17.04.2013)
- Cromos™ Pharma at 49th Annual DIA Meeting in Boston, USA on 23-27 June 2013 (11.06.2013)
- Cromos™ Pharma begins operations in Belarus (25.06.2013)
- Cromos™ Pharma at European Cancer Congress 2013 (ECCO-ESMO-ESTRO) in Amsterdam, The Netherlands on 27 September – 01 October 2013 (27.08.2013)
- Cromos™ Pharma at Outsourcing in Clinical Trials New England 2013 conference, Boston, MA, USA on 1-2 October 2013 (28.08.2013)
- Cromos™ Pharma at MedInIreland conference in Dublin, Ireland on 23 October 2013 (10.10.2013)
- Dr. Vlad Bogin, Cromos Pharma's CEO authors an article titled "All Global Clinical Trials Are Local" in the Journal of Clinical Research Best Practices (03.11.2013)
- Cromos™ Pharma at ASH Annual Meeting in New Orleans, LA, USA on 7-10 December 2013 (25.11.2013)
- Cromos Pharma's CEO, Dr Vlad Bogin will attend JPMorgan Healthcare Conference in San Francisco, USA on 13-16 January 2014 (25.12.2013)
- CLINICAL TRIALS AND RESEARCH IN ISRAEL (16.01.2014)
- Cromos Pharma at Scope Summit 2014 in Miami (FL), USA on 4-6 February 2014 (21.01.2014)
- Cromos Pharma at Partnerships in Clinical Trials Conference in Las Vegas, USA on 30 March – 02 April 2014 (14.03.2014)
- Cromos Pharma invites to the 3rd annual Clinical Trial Oversight Summit in Boston, MA (USA) on 2-5 June 2014, where Cromos Pharma's CEO, Dr. Vlad Bogin will be speaking about implementation of risk-based monitoring in international clinical trials (09.04.2014)
- Cromos Pharma’s CEO, Dr. Vlad Bogin, will attend Boston Biotech CEO Conference which assembles CEOs and decision makers in the international pharmaceutical industry. The forum takes place on 4-5 June, 2014 at Four Seasons Hotel in Boston, MA (USA) (24.04.2014)
- Cromos Pharma Video Presentation (17.05.2014)
- As the debate about "strategic" vs. "transactional" relationship between Pharma and CROs goes on, we thought that you might enjoy a viewpoint of an independent regional player (27.06.2014)
- WEBINAR: SWOT analysis of clinical trials in post-Soviet countries (31.07.2014)
- Cromos™ Pharma CEO, Dr. Bogin, will be presenting at MAGI Clinical Research Conference that takes place in San Francisco on November 9-12, 2014 (06.10.2014)
- Cromos™ Pharma at New York CEO Conference (06.10.2014)
- Cromos™ Pharma launches risk-sharing partnerships program with biotech and pharma companies (14.12.2014)
- Cromos™ Pharma invites you to Annual Charitable Pharma Football Cup (29.12.2014)
- Cromos™ Pharma's capabilities presentation at Cardiovascular innovations showcase coinciding with the 33rd Annual J.P. Morgan Healthcare Conference (07.01.2015)
- Cromos Pharma’s country head in Georgia gives narrative on clinical trials to Rustavi 2 TV channel (02.02.2015)
- Our First Annual Moscow Charitable Football Cup held on January 31st, 2015 was a smashing success! (04.02.2015)
- Cromos Pharma's CEO, Dr. Vlad Bogin will be speaking at the Boston Biotech CEO Conference that takes place in Boston, USA on 26-27 May 2015 (15.03.2015)
- Cromos Pharma's CEO Dr. Vlad Bogin has joined the board of directors of Batu Biologics (05.05.2015)
- International Clinical Trials' Day (19.05.2015)
- Cromos™ Pharma at the 23rd World Congress of Dermatology 8-13 June 2015 in Vancouver, Canada (24.05.2015)
- Cromos™ Pharma opens a representative office in Czech Republic (04.08.2015)
- Meet Cromos Pharma at BioJapan 2015 on 14-16 October 2015 (03.09.2015)
- Cromos™ Pharma at European Cancer Congress 2015 (ECCO-ESMO) in Vienna, Austria on 25-29 September 2015 (09.09.2015)
- Cromos Pharma's CEO, Dr. Vlad Bogin will participate in Neuro Advance Boston conference that takes place in Boston, USA on 14 October 2015 (17.09.2015)
- Our update on the study start up times in selected countries of Central and Eastern Europe where Cromos Pharma operates (Journal of Clinical Research Best Practices) (02.10.2015)
- Cromos™ Pharma announces the launch of No Patients - No Payments™ initiative (28.10.2015)
- Cromos™ Pharma at the 2015 San Antonio Breast Cancer Symposium (20.11.2015)
- Cromos Pharma's CEO and Founder, Dr Vlad Bogin will attend the 34th Annual J.P. Morgan Healthcare Conference, January 11 - 14, 2016 in San Francisco (09.12.2015)
- Cromos™ Pharma opens a representative office in Hungary (12.01.2016)
- Cromos™ Pharma at the Swiss Biotech Day in Basel on 12 April 2016 (30.03.2016)
- Cromos Pharma published a new article on Feasibilty in Applied Clinical Trials Journal (25.04.2016)
- Cromos™ Pharma at XIV.BIONNALE 2016 in Berlin, Germany, on 25 May (28.04.2016)
- Cromos Pharma’s CEO and Founder, Dr. Vlad Bogin, will be attending the American Society of Clinical Oncology (ASCO) congress 2016 in Chicago, Illinois, USA, which will run on June 3rd – 7th, 2016 (17.05.2016)
- We at Cromos Pharma are always interested in what makes a sponsor choose a certain CRO (31.05.2016)
- Meet Cromos Pharma's Business Development Director, Dr. Vladimir Krechikov in Stockholm, Sweden at the Nordic Life Science Days 2016 Conference (NLSDays 2016) on 14-15 September (02.08.2016)
- The 35th Annual J.P. Morgan Healthcare Conference, January 09 - 12, 2017 in San Francisco, CA, USA (12.09.2016)
- DUBLIN, IRELAND--(Marketwired - October 24, 2016) - Cromos™ Pharma, a premier regional contract research organization announced today that Dr. Gearóid Tuohy has been appointed... (24.10.2016)
- Cromos Pharma has published a white paper that gives a comprehensive overview of clinical trial landscape in the Republic of Georgia, which is becoming a very attractive location for clinical trials (09.11.2016)
- Meet Cromos Pharma’s CEO, Dr. Vlad Bogin in San Antonio, Texas at San Antonio Breast Cancer Symposium (SABCS 2016) on December 6-10, 2016 (22.11.2016)
- Meet Cromos Pharma’s VP, International Business & Operations, Dr. Gearóid Tuohy in London at Clinical Innovation and Partnering World 2017 on 8-9 March 2017 (05.02.2017)
- Cromos™ Pharma received regulatory approval for the first ever ophthalmological clinical trial in Georgia (20.02.2017)
- Cromos™ Pharma has published a white paper on the new EU clinical trial regulation (no. 536/2014) and investigator-led studies (13.03.2017)
- Join Cromos™ Pharma At The Clinical Trial Innovation Summit 2017, 24-26 April 2017, Boston, USA (02.04.2017)
- Cromos Pharma at the Swiss Biotech Day in Basel on 4 May 2017 (19.04.2017)
- Cromos™ Pharma's CEO to speak at MAGI Clinical Research Conference in Philadelphia, USA (21-24 May, 2017) (30.04.2017)
- Meet us at BIO International Convention 2017 in San Diego, CA, USA on 19-22 June, 2017 (14.05.2017)
- Cromos Pharma begins operations in Kazakhstan (11.07.2017)
- Join Cromos™ Pharma at the Nordic Life Science Days on September 12 - 14, 2017 in Malmö, Sweden (13.08.2017)
- Cromos™ Pharma at the Outsourcing in Clinical Trials Southern California in La Jolla (Ca), USA on 27-28 September 2017 (27.08.2017)
- Cromos™ Pharma shares its experience with clinical trials in Kazakhstan in Applied Clinical Trials (02.10.2017)
- 2018 J.P. Morgan 36th annual Healthcare Conference (20.11.2017)
- Stephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprint (11.12.2017)
- Join Cromos™ Pharma at the 9th annual SCOPE Summit 2018 (31.01.2018)
- Meet us at BIO International Convention 2018 in Boston, MA, USA on 4-7 June, 2018 (04.04.2018)
- Join Cromos™ Pharma at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, USA on 1-5 June, 2018 (11.04.2018)
- Cromos Pharma CEO presents a case study of a rescue clinical trial (12.07.2018)
- Cromos™ Pharma Attends the 2nd Annual Accelerating Clinical Trials Conference in Asia 2018 (19.08.2018)
- Clinical Trials in Poland: Statistics of the First Half of 2018 (26.09.2018)
- Cromos Pharma celebrates Breast Cancer Awareness Month (14.10.2018)
- The XX Hungarian Clinical Pharmacology Congress (02.12.2018)
- 2019 J.P. Morgan 37th Annual Healthcare Conference (09.12.2018)
- Join Cromos™ Pharma at the 12th European Biosimilars Congress in Berlin, Germany on 15-16 April, 2019 (25.03.2019)
- Meet us at the 11th Dia China Annual Meeting 2019 in Beijing, China on 20-23 May, 2019 (29.04.2019)
- Meet us at Asco Annual Meeting 2019 In Chicago, USA on May 31 – June 4, 2019 (12.05.2019)
- Join us at Bio in Philadelphia on June 3-6, 2019 (15.05.2019)
- Cromos Pharma recruits 473 patients (92% of total) into a breast cancer trial, all in under 7 months. (16.06.2019)
- Cromos Pharma's "Your Perfect CRO" Survey shows surprising results (23.07.2019)
- Cromos Pharma sets a new record in site initiation timelines in Poland (14.08.2019)
- Cromos Pharma CEO highlights opportunities and challenges for small sponsors at MAGI Clinical Research Conference (19.08.2019)
- Meet the Cromos Pharma team at the 2019 KoNECT-MOHW-MFDS International Conference to be held on September 17 – 19 in Seoul, South Korea. (29.08.2019)
- Join us at ESMO in Barcelona on September 27 - October 1, 2019 (18.09.2019)
- Meet us at Outsourcing in Clinical Trials Pacific Northwest in Seattle on October 16 - 17, 2019 (18.09.2019)
- Cromos Pharma celebrates Breast Cancer Awareness Month (02.10.2019)
- Our medical writing team is focused on delivering the results you need. (30.10.2019)
- Thanksgiving Message (26.11.2019)
- Meet Cromos Pharma at 61st ASH Annual Meeting & Exposition (28.11.2019)
- Thank you for your business and support throughout 2019. We look forward to working with you in 2020! (16.12.2019)
- Master Protocols (20.01.2020)
- Cromos Pharma attends Asia Matters briefing (21.01.2020)
- Cromos Pharma launches a new office in Warsaw, Poland (04.03.2020)
- Celebrating the Women of Cromos Pharma on IWD 2020 (08.03.2020)
- Cromos Pharma launches new series to explore the latest developments in clinical trials sector (09.03.2020)
- Cromos Pharma committed to delivering in the face of COVID-19 challenges (13.03.2020)
- Cromos Pharma to run COVID-19 trial (01.04.2020)
- European Medicines Agency launches new regulatory science strategy (08.04.2020)
- Cromos Pharma wishes you a safe and healthy Easter and Passover (10.04.2020)
- Cromos Pharma supporting World Immunization Week (23.04.2020)
- Working through COVID-19 (25.04.2020)
- First patients enrolled in Cromos Pharma managed Covid-19 trial (27.04.2020)
- Clinical Trials Day (20.05.2020)
- Cromos Pharma celebrates International Clinical Trials Day 2020 (20.05.2020)
- Cromos Pharma insights on master protocols (27.05.2020)
- Your Trial Post-COVID Must Start Now (30.05.2020)
- Connect with Cromos Pharma at BIO Digital 2020 (02.06.2020)
- Watch our webinar: Your Trial Post-Covid: Recovery Must Start Now (10.06.2020)
- Clinical characteristics of dermatologic manifestations of COVID‐19 infection (14.06.2020)
- Cromos Pharma Recruits over 300 Patients in Under Two Months into a COVID-19 Clinical Trial (18.06.2020)
- FDA launches pioneering pilot to make public patient reported outcomes of clinical trials (23.06.2020)
- EU Clinical Trials Information System set to go live end of 2021 (24.06.2020)
- Risk Based Monitoring- a data-centric approach to monitoring (30.06.2020)
- Cromos Pharma- navigating an era of uncertainty (10.07.2020)
- Two new reports find impacts of COVID-19 on clinical trials easing slightly (13.07.2020)
- European medicines agencies launch public consultation on joint strategy (14.07.2020)
- American Association for Cancer Research Forum addresses racism and inequality in cancer trials (21.07.2020)
- EU cancer estimates for 2020 reveal 2.7 million new cases (26.07.2020)
- FDA proposes new rule on reporting requirements to support Right to Try (26.07.2020)
- Clinical Trials Market Size, Share & Trends Analysis Report: Research and Markets (28.07.2020)
- Cromos Pharma supporting Psoriasis Awareness Month (06.08.2020)
- Over a third of oncology trials disrupted by COVID-19 resume: GlobalData (16.08.2020)
- Cromos Pharma and Avance Clinical Offer Scalable Clinical Trial Solution for Biotech (26.08.2020)
- Clinical characteristics of dermatologic manifestations of COVID‐19 infection (26.08.2020)
- Webinar: Where in the world should I locate my pivotal clinical trial? (01.09.2020)
- Watch our video: Navigating an era of uncertainty (02.09.2020)
- Biosimilars: Opportunities, Challenges and the Future for a Sustainable Global Market (15.09.2020)
- Connect with Cromos Pharma at MAGI's Clinical Research vConference (17.09.2020)
- Watch Webinar: Where in the world should I locate my pivotal clinical trial? (24.09.2020)
- Alzheimer's Awareness Month: Q&A with Dr Sabina Brennan (28.09.2020)
- Cromos Pharma at BIO-Europe Digital Oct 26-29 (06.10.2020)
- Video: Cromos Pharma and Avance Clinical Collaboration (08.10.2020)
- Cromos Pharma and Avance Clinical launch scalable clinical trial solution for biotech (08.10.2020)
- Biosimilars: US and Europe (26.10.2020)
- Orphan Drugs Market to Reach USD 340.84 Billion by 2027 (26.10.2020)
- Cromos Pharma at GRx+Biosims November 9-11, 2020 (26.10.2020)
- Join Cromos Pharma at World Orphan Drug Congress-Europe 2020 (27.10.2020)
- Cromos Pharma and Avance Clinical share details of innovative collaboration at BIO-Europe 2020 (28.10.2020)
- FDA Offers Guidance to Enhance Diversity in Clinical Trials (12.11.2020)
- World Pancreatic Cancer Awareness Day 2020 (19.11.2020)
- Thanksgiving Greetings (20.11.2020)
- Learn more about Cromos Pharma and Avance Clinical's Euro-Australian collaboration for biotechs (20.11.2020)
- Meet Cromos Pharma at the 62nd ASH Annual Meeting & Exposition (24.11.2020)
- Cromos Pharma at The San Antonio Breast Cancer Symposium 2020 (30.11.2020)
- World AIDS Day 2020: Remarkable progress but the fight continues (01.12.2020)
- Watch: The benefits of Cromos Pharma and Avance Clinical's biotech initiative (08.12.2020)
- Happy Hanukkah from Cromos Pharma (10.12.2020)
- Cromos Pharma Is Hosting a Virtual Booth At 2021 JPM Healthcare Conference (20.12.2020)
- Seasons Greetings from Cromos Pharma (22.12.2020)
- Seasons Greetings from Cromos Pharma (23.12.2020)
- Visit our Virtual Booth at the JP Morgan Healthcare Conference 2021 (30.12.2020)
- JP Morgan Healthcare Conference: Virtual Booth and Daily Presentations (01.01.2021)
- Global vaccine rollout underway as COVID-19 cases surge (07.01.2021)
- Reaping the benefits of a Euro-Australian collaboration for biotechs: save on costs and time (18.01.2021)
- Clinical trials: how to enroll on time, stay on budget and not compromise data quality (23.01.2021)
- Reaping the benefits of a Euro-Australian collaboration for biotechs: save on costs and time (24.01.2021)
- Clinical trials in the time of COVID: Risks, mitigation and lessons learned (24.01.2021)
- Upcoming EU drug/device legislation: What you need to know (25.01.2021)
- European Medicines Agency: Approvals January 2021 (31.01.2021)
- Cromos Pharma offers EU Legal Representative Service (04.02.2021)
- World Cancer Day 2021: Cromos Pharma is committed to supporting clinical research to make cancer breakthroughs (04.02.2021)
- Top 5 reasons to locate your next clinical trial in Hungary (09.02.2021)
- International Women and Girls in Science Day (11.02.2021)
- Upcoming EU drug/device legislation: What you need to know (15.02.2021)
- Cromos Pharma at OCT West Coast 2021 (17.02.2021)
- Key factors to consider for rare disease/orphan drug development (26.02.2021)
- Meet with us at DIA Europe 15 - 19 March (02.03.2021)
- Cromos CEO outlines advantages of Central and Eastern Europe for clinical trials (04.03.2021)
- IWD2021: Championing Women making healthcare breakthroughs (08.03.2021)
- Meet us during Bio-Europe Spring 22 -25 March (09.03.2021)
- Meet us during BIO-Europe Spring 22 -25 March (09.03.2021)
- Cromos Pharma charting new territories as it looks east to Uzbekistan (11.03.2021)
- Cromos Pharma appoints new Business Development Director for Central and Eastern Europe (21.03.2021)
- Data management and Biostatistics solutions to ensure the quality of your data (23.03.2021)
- Colorectal Cancer Awareness Month (25.03.2021)
- Colorectal Cancer: A survivor's story (30.03.2021)
- Simple Math for Clinical Trial Success (31.03.2021)
- Clinical Trials in Georgia (31.03.2021)
- Reasons why Georgia needs to be on your list of locations for clinical trials (06.04.2021)
- EU drug and device legislation: What you need to know (28.04.2021)
- Clinical trial of RPH-104 in acute ST-Elevation Myocardial Infarction: Design and Rationale (29.04.2021)
- Join us at Bio Digital and Oct Eastern Europe this June (11.05.2021)
- Cromos Pharma supporting mental health at work (18.05.2021)
- Cromos Pharma celebrates International Clinical Trials Day 2021 (20.05.2021)
- Join Cromos Pharma's Vlad Bogin at OCT Eastern Europe June 15 (24.05.2021)
- Looking ahead to 2021 ASCO Annual Meeting: Oncology (26.05.2021)
- Connect with us during BIO Digital 14 - 18 June (01.06.2021)
- Cromos Pharma celebrates International Children's Day 2021 (01.06.2021)
- Clinical trials: how to enroll on time, stay on budget and not compromise data quality (05.06.2021)
- Free Feasibility Reports Initiative Video (07.06.2021)
- FDA approves first new Alzheimer's drug in 20 years (10.06.2021)
- Cromos Pharma at BIO Digital 14 - 18 June (14.06.2021)
- Cromos Pharma on why Central and Eastern Europe are the hottest locations for clinical trials (16.06.2021)
- Watch Cromos Pharma explain the benefits of locating your clinical trial in Central and Eastern Europe (16.06.2021)
- Clinical trials in the time of COVID: Risks, mitigation and lessons learned (20.06.2021)
- Cromos Pharma on best practice for a well-designed clinical study protocol (22.06.2021)
- Cromos Pharma celebrates Cancer Survivors Month (24.06.2021)
- Conducting Clinical Trials in Poland - Country Profile 2021 (29.06.2021)
- Cromos Pharma on the advantages of conducting clinical trials in Poland (29.06.2021)
- Cromos Pharma outlines the benefits of locating your clinical trial in Poland (02.07.2021)
- Cromos Pharma on the latest EU Medical Device Regulation (09.07.2021)
- Cromos Pharma highlights Sarcoma Awareness Month (13.07.2021)
- Cromos Pharma's US BDD on COVID's impact on clinical research and recover for clinical trials sector (15.07.2021)
- Decentralized Clinical Trials: Are they here to stay? (20.07.2021)
- World Hepatitis Day and the role of clinical research (27.07.2021)
- Cromos Pharma on the upcoming implementation of EU Clinical Trial Regulation (29.07.2021)
- What will the upcoming Clinical Trial Regulation mean for the conduct of trials in the EU? (29.07.2021)
- Cromos Pharma explains new EU Medical Device Regulation (03.08.2021)
- Reaping the benefits of eCONSENT for clinical trials (10.08.2021)
- Cromos Pharma supporting psoriasis clinical research breakthroughs (12.08.2021)
- Meet Cromos Pharma during World Orphan Drug Congress US August 2021 (17.08.2021)
- Cromos Pharma committed to patient centricity in clinical trials (19.08.2021)
- Rare disease clinical trials factsheet (24.08.2021)
- Cromos Pharma on rare disease drug development (24.08.2021)
- Getting ready for full implementation of the EU Clinical Trial Regulation (26.08.2021)
- Cromos Pharma's Patient Portal now available in multiple languages (07.09.2021)
- 5 key takeaways from World Orphan Drug Congress USA (09.09.2021)
- Cromos Pharma committed to supporting clinical research into Alzheimer's disease (14.09.2021)
- Cromos Pharma successfully completes enrollment for a Phase II COVID-19 vaccine clinical trial (16.09.2021)
- Cromos Pharma at San Antonio Breast Cancer Symposium 2021 (17.09.2021)
- Cromos Pharma at San Antonio Breast Cancer Symposium 2021 (17.09.2021)
- Connect with Cromos Pharma at BIO-Europe October 25–28, 2021 (21.09.2021)
- Cromos Pharma supporting Blood Cancer Awareness Month (21.09.2021)
- Conducting clinical trials in the Czech Republic with Cromos Pharma (23.09.2021)
- Cromos Pharma supporting clinical research to beat heart disease (28.09.2021)
- Cromos Pharma making sure your clinical trial is feasible (05.10.2021)
- Сlinical trials in the Czech Republic - Country Profile 2021 (07.10.2021)
- Cromos Pharma at 40th JP Morgan Healthcare Conference (28.10.2021)
- Connect with Cromos Pharma at 40th JP Morgan Healthcare Conference (28.10.2021)
- Cromos Pharma delivering clinical trial success in breast cancer studies (28.10.2021)
- Get ready for EU CTR implementation with Cromos Pharma (02.11.2021)
- Cromos Pharma supporting lung cancer clinical trials (04.11.2021)
- Unlocking the potential of biosimilars with Cromos Pharma (11.11.2021)
- Meet with Cromos Pharma during the San Antonio Breast Cancer Symposium (16.11.2021)
- Cromos Pharma delivering high quality data for clinical trial success (23.11.2021)
- eCONSENT and clinical trials (29.11.2021)
- Cromos Pharma supporting clinical trials to advance HIV treatments (01.12.2021)
- Connect with Cromos Pharma at the 40th JP Morgan Healthcare Conference (14.12.2021)
- Cromos Pharma celebrates drug discoveries that have changed the world (17.12.2021)
- Cromos named top Quality Assurance service provider by Pharma Tech Outlook (11.01.2022)
- Meet Cromos Pharma at SCOPE 2022 (12.01.2022)
- Meet Cromos Pharma at SCOPE 2022 (12.01.2022)
- Cromos Pharma on clinical trial trends for 2022 (18.01.2022)
- No Patients - No Payment™ risk-sharing program explained (20.01.2022)
- Clinical Research Focus. 1st Edition (02.02.2022)
- Cromos Pharma launches clinical research focus newsletter (03.02.2022)
- A new era for clinical trials in Europe (08.02.2022)
- 7 steps for successful clinical trial protocol design (10.02.2022)
- The role of decentralized approaches in clinical trials (15.02.2022)
- Key takeaways from Scope 2022 (22.02.2022)
- Celebrating women's contribution to clinical research (08.03.2022)
- Clinical Research Focus. 2nd Edition (09.03.2022)
- Patient recruitment challenges for clinical trials (09.03.2022)
- Lasagna's Law: Patient Recruitment and Clinical Trials (09.03.2022)
- Cromos Pharma's Clinical Research Focus March 2022 (21.03.2022)
- Clinical Trials in Hungary - Country Profile 2022 (21.03.2022)
- Lasagna's Law and patient recruitment (21.03.2022)
- Connect with Cromos Pharma at BIO-Europe Spring (21.03.2022)
- Сlinical trials in Georgia - Country Profile 2022 (04.04.2022)
- Clinical Research Focus. 3rd Edition (04.04.2022)
- Clinical Trials Disrupted During War in Ukraine (13.04.2022)
- Meet Cromos Pharma at the ASCO Annual Meeting 2022 (18.04.2022)
- Сlinical trials in Poland - Country Profile 2022 (05.05.2022)
- Meet Cromos Pharma at the BIO International Convention 2022 (06.05.2022)
- Clinical Research Focus. 4th Edition (06.05.2022)
- Cromos Pharma Names New Country Head in Poland (12.05.2022)
- Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy (17.05.2022)
- An Unseen Cost of the Ukraine War (29.05.2022)
- Cromos Pharma Committed to Patient Centricity in Clinical Trials (31.05.2022)
- Сlinical trials in the Czech Republic – Country Profile 2022 (09.06.2022)
- Clinical Research Focus. 5th Edition (09.06.2022)
- Key Takeaways from ASCO Annual Meeting 2022 (15.06.2022)
- Key Takeaways from the BIO International Convention 2022 (23.06.2022)
- Clinical Research Focus. 6th Edition (07.07.2022)
- Patients’ Portal: New Languages added (08.07.2022)
- Medical Writing Guidelines (14.07.2022)
- Choosing The Right CRO For Your Clinical Trials (21.07.2022)
- Monkeypox was Declared a Global Health Emergency by WHO (26.07.2022)
- Clinical Research Focus. 7th Edition (03.08.2022)
- Cromos Pharma Highlights Psoriasis Awareness and Action Month (05.08.2022)
- How To Improve Patient Recruitment in Clinical Trials? (09.08.2022)
- Decentralized Clinical Trials. What does the future hold? (11.08.2022)
- August is National Immunization Awareness Month- Cromos Pharma (16.08.2022)
- Meet Cromos Pharma at ESMO Congress 2022 in Paris (18.08.2022)
- Cromos Pharma continues to battle COVID-19 (23.08.2022)
- eConsent and Clinical Trials (25.08.2022)
- IRB Submission of Drugs (30.08.2022)
- Clinical Research Focus. 8th Edition (06.09.2022)
- Wearable Devices for Remote Monitoring in Clinical Trials (08.09.2022)
- Biostatistics in Clinical Trials (13.09.2022)
- World Lymphoma Awareness Day 2022 (15.09.2022)
- Meet Cromos Pharma at BIO-Europe 2022 in Leipzig (19.09.2022)
- Cromos Pharma Solidifies Its Operational Presence in Türkiye, Kazakhstan and Serbia (20.09.2022)
- Clinical Trials in Kazakhstan (22.09.2022)
- Kazakhstan Country Profile (22.09.2022)
- Clinical Trials in Kazakhstan - Country Profile for 2022 (27.09.2022)
- World Heart Day 2022 (29.09.2022)
- Clinical Research Focus. 9th Edition (06.10.2022)
- Clinical Trials in Türkiye (13.10.2022)
- Türkiye Country Profile (13.10.2022)
- Breast Cancer Awareness Month 2022 (18.10.2022)
- Connect with Cromos Pharma at ChinaBIO 2022 (19.10.2022)
- Türkiye - a Hidden Gem in Clinical Research (20.10.2022)
- Happy Halloween from Cromos Pharma! (31.10.2022)
- New Chinese and Korean Website Pages (01.11.2022)
- The Not so Rare “Rare” Diseases (08.11.2022)
- Key Takeaways from BIO-Europe 2022 (10.11.2022)
- World Diabetes Day 2022 (14.11.2022)
- Clinical Research Focus. 10th Edition (15.11.2022)
- Pharma Lingo with Cromos Pharma: Clinical Trials or Clinical Studies? (17.11.2022)
- Pharma Lingo: Clinical Trials or Clinical Studies? (17.11.2022)
- Clinical Trials in Serbia (22.11.2022)
- Serbia Country Profile (22.11.2022)
- Happy Thanksgiving from Cromos Pharma! (23.11.2022)
- Meet Cromos Pharma at J.P. Morgan 2023 (28.11.2022)
- Serbia is a land of opportunity for clinical research (29.11.2022)
- Clinical Research Focus. 11th Edition (06.12.2022)
- Cromos Pharma’s Guide to the EU Legal Representation Requirements (13.12.2022)
- Cromos Pharma Welcomes New CT Project Manager in Eastern Europe (15.12.2022)
- Happy Hanukkah from Cromos Pharma! (16.12.2022)
- Evolution of Clinical Trials 2023 (21.12.2022)
- Season's Greetings from Cromos Pharma 2023 (21.12.2022)
- Cromos Pharma Highlights Liver Cancer and Viral Hepatitis Awareness and Prevention Month (12.01.2023)
- Clinical Research Focus. 12th Edition (17.01.2023)
- Cromos Pharma Welcomes New Associate Business Development Director in Europe (19.01.2023)
- Happy Chinese New Year from Cromos Pharma! (20.01.2023)
- Meet Cromos Pharma at SCOPE 2023! (23.01.2023)
- JPM 2023 Healthcare Conference: Key Takeaways for Biotech Companies (24.01.2023)
- The Unexpected Benefits of Patient Centricity in Clinical Research (30.01.2023)
- World Cancer Day 2023 (03.02.2023)
- Clinical Research Focus. 13th Edition (07.02.2023)
- Happy Valentine's Day! (14.02.2023)
- Clinical Trials in Romania (20.02.2023)
- Romania Country Profile (21.02.2023)
- Phasing out of Animal Testing for Next Generation Drugs (22.02.2023)
- Key Takeaways from SCOPE Summit 2023 (23.02.2023)
- Clinical Trials in Romania – So Much to be Discovered (02.03.2023)
- Clinical Research Focus. 14th Edition (07.03.2023)
- World Kidney Day 2023 (09.03.2023)
- The Current State of Clinical Trials in Ukraine (16.03.2023)
- Happy St. Patrick's Day! (17.03.2023)
- Meet Cromos Pharma at AACR Annual Meeting 2023! (21.03.2023)
- Clinical Trials in Bulgaria (23.03.2023)
- Bulgaria Country Profile (23.03.2023)
- World Autism Acceptance Week 2023 (27.03.2023)
- Clinical Trials in Bulgaria – Country Profile for 2023 (29.03.2023)
- Clinical Research Focus. 15th Edition (04.04.2023)
- Happy Passover! (06.04.2023)
- Happy Easter! (07.04.2023)
- World Hemophilia Day 2023 (17.04.2023)
- Cromos Pharma Appoints Elçin Gulistanoglu as New Head of Operations in Türkiye (19.04.2023)
- Meet Cromos Pharma at World Orphan Drug Congress 2023! (21.04.2023)
- Clinical Trials in Hungary – Country Profile for 2023 (26.04.2023)
- Hungary Country Profile (26.04.2023)
- Key Takeaways from AACR Annual Meeting 2023 (28.04.2023)
- Revision of the EU Pharmaceutical Legislation: the Changes Are Major and the Impact Will Be Significant (28.04.2023)
- Clinical Research Focus. 16th Edition (02.05.2023)
- Meet Cromos Pharma at the ASCO Annual Meeting! (04.05.2023)
- Meet Cromos Pharma at ASCO 2023! (04.05.2023)
- FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance (09.05.2023)
- Meet Cromos Pharma at the BIO International Convention 2023! (11.05.2023)
- Meet Cromos Pharma at BIO International Convention! (11.05.2023)
- The Pros and Cons of the FDA’s Real-Time Oncology Review Program (16.05.2023)
- Meet Cromos Pharma at the Clinical Trials Nexus Conference! (18.05.2023)
- Clinical Trials Day 2023 (19.05.2023)
- Clinical Trial Success Starts with an Airtight Protocol (22.05.2023)
- Clinical Trials in the Baltic States – Countries' Profile for 2023 (25.05.2023)
- The Baltic States Countries' Profile (01.06.2023)
- Clinical Research Focus. 17th Edition (06.06.2023)
- Cromos Pharma’s CEO to Present at the 17th BioPharma Nexus Conference (08.06.2023)
- Diabetes Awareness Week 2023 (13.06.2023)
- Cromos Pharma’s CEO Participated as a Speaker in the BioPharma Nexus Conference (19.06.2023)
- Insights from ASCO 2023 (19.06.2023)
- Poland: A Thriving Hub for Biotech Advancements and Clinical Trials (27.06.2023)
- Poland Country Profile (29.06.2023)
- Happy Independence Day 2023 (03.07.2023)
- Meet Cromos Pharma at the Clinical Operations in Oncology Trials East Coast 2023! (05.07.2023)
- Clinical Research Focus. 18th Edition (06.07.2023)
- Regulatory Focus Shifts: Expanding Role of Real-World Evidence for Evaluating New and Expanded Drug Indications (11.07.2023)
- Hemochromatosis Screening And Awareness Month (13.07.2023)
- Addressing the Underrepresentation of Older Adults in Cancer CT: Advancing Inclusion for Improved Care (18.07.2023)
- Clinical Trials in the Czech Republic: A Prominent Hub for Scientific Discovery and Cost Optimization (25.07.2023)
- The Czech Republic Country Profile (27.07.2023)
- Advancing Clinical Trial Diversity: A Step Towards Equitable Healthcare (01.08.2023)
- Clinical Research Focus. 19th Edition (03.08.2023)
- Empowering Patient Recruitment with Cromos Pharma: The Invaluable Role of Explainer Videos (15.08.2023)
- Decentralized Clinical Trials: Balancing the Promise and Pitfalls in Cost, Recruitment, and Patient Satisfaction (17.08.2023)
- Cromos Pharma Contemplates Complex International GMO Research Program Regulations (23.08.2023)
- Cromos Pharma commences a pivotal multicountry clinical trial of OT-101 in patients with advanced pancreatic cancer (24.08.2023)
- EMA Releases a Reflection Paper on the Role of AI in Drug Development (31.08.2023)
- Happy Labor Day 2023 (01.09.2023)
- Clinical Research Focus. 20th Edition (05.09.2023)
- Cancer research challenges in Ukraine (07.09.2023)
- Meet Cromos Pharma at the Global Site Solutions Summit 2023! (13.09.2023)
- Understanding ARR, RRR and NNT (14.09.2023)
- Meet Cromos Pharma at the 18th Biopharma Clinical Trials Nexus Conference (18.09.2023)
- Cromos Pharma’s Free Multicountry Feasibility Report (21.09.2023)
- Cromos Pharma’s Free Multicountry Feasibility Report (21.09.2023)
- Debating the Role of Interchangeability in Biosimilar Development (26.09.2023)
- Meet Vlad Bogin at the ESMO 2023 Congress (28.09.2023)
- Clinical Research Focus. 21st Edition (03.10.2023)
- Vlad Bogin will chair the 18th Biopharma Clinical Trials Nexus (05.10.2023)
- Vlad Bogin will chair the 18th Biopharma Clinical Trials Nexus (05.10.2023)
- Meet Cromos Pharma at the SITC 38th Annual Meeting 2023 (10.10.2023)
- FDA Initiates Formation of a New Advisory Committee for Digital Health Technologies (13.10.2023)
- Enhancing Oncology Drug Dosage Optimization: Project Optimus (17.10.2023)
- Meet Vlad Bogin at CPHI Barcelona 2023 (19.10.2023)
- Fit-for-Purpose Biotech – CRO Collaboration: The FSP Model (24.10.2023)
- Happy Halloween 2023 (31.10.2023)
- Cromos Pharma's CEO Reflections on ESMO 2023: A Glimpse into The Future Of Oncology (02.11.2023)
- Clinical Research Focus. 22nd Edition (07.11.2023)
- Navigating the Challenging Biotech Funding Landscape (09.11.2023)
- New Weight Loss Drug Zepbound Receives FDA Approval Amid Calls for Comprehensive Coverage of Obesity Treatments (15.11.2023)
- Meet Vlad Bogin at ASH 2023 (20.11.2023)
- Happy Thanksgiving Day 2023 (22.11.2023)
- Shining a Spotlight on Diabetes Awareness Month: The Vital Role of Clinical Trials (30.11.2023)
- Meet Vlad Bogin at ASH 2023 (04.12.2023)
- Clinical Research Focus. 23rd Edition (05.12.2023)
- Happy Hanukkah 2023 (07.12.2023)
- FDA Greenlights Groundbreaking Gene Therapies for Sickle Cell Disease (12.12.2023)
- Revitalizing Biotech: Navigating Efficient Clinical Trials Amid Financial Constraints (14.12.2023)
- Meet Cromos Pharma at 42nd Annual J.P. Morgan Healthcare Conference (15.12.2023)
- Key Highlights in Clinical Research and Healthcare for 2023 (18.12.2023)
- Health Awareness Journey with Cromos Pharma | New Year 2024 (20.12.2023)
- Exploring Groundbreaking Advances: Key Insights from ASH 2023 (27.12.2023)
- Clinical Research Focus. 24th Edition (08.01.2024)
- Cromos Pharma’s umbrellas are a hit (09.01.2024)
- Meet Cromos Pharma at the SCOPE SUMMIT 2024 (11.01.2024)
- Pragmatic Clinical Trials in 2024 (16.01.2024)
- Cromos Pharma's new Country Head for Türkiye (18.01.2024)
- J.P. Morgan's Healthcare Conference: A Glimpse into the Optimistic Pulse of 2024 (22.01.2024)
- Türkiye's Emerging Role in Clinical Research: Regulatory Updates and Simplified Processes (24.01.2024)
- Meet Cromos Pharma at the Texas BioLife Summit 2024 (01.02.2024)
- Navigating the Future of Gene Therapy (06.02.2024)
- Clinical Research Focus. 25th Edition (08.02.2024)
- Cromos Pharma’s Team at SCOPE 2024 (14.02.2024)
- Celebrating Rare Disease Day 2024 (29.02.2024)
- Clinical Research Focus. 26th Edition (05.03.2024)
- Cromos Pharma's new Country Head for Poland (07.03.2024)
- The Invaluable Role of Explainer Videos (12.03.2024)
- World Kidney Day 2024 (14.03.2024)
- Exploring Clinical Trial Opportunities: Hungary's 2024 Country Profile (19.03.2024)
- Navigating the Challenges: The Impact of US-China Tensions on Biopharmaceutical Innovation (21.03.2024)
- Revolutionizing Diabetes Management: FDA Approves First Direct-to-Consumer Glucose Monitor (26.03.2024)
- Clinical Research Focus. 27th Edition (02.04.2024)
- Сlinical Trials in Georgia 2024 (11.04.2024)
- Rezdiffra Approval Sheds Light on the Challenges of NASH Diagnosis and Fibrosis Identification (16.04.2024)
- Cromos Pharma's Strategic Meeting in Warsaw (18.04.2024)
- Meet us at the BioNJ BioPartnering Conference 2024 (24.04.2024)
- Cromos Pharma's Strategic Meeting in Miami (25.04.2024)
- Anticipating ASCO: Key Trends in Oncology Clinical Research (30.04.2024)
- Meet us at the BIO International Convention 2024 (03.05.2024)
- Ukraine Strives to Remain a Hub for Clinical Trials Despite Conflict (07.05.2024)
- Clinical Research Focus. 28th Edition (08.05.2024)
- Cromos Pharma's Country Head Speaks at GCP Training Event in Istanbul (09.05.2024)
- Deep dive into Clinical Trials Specifics in Türkiye (14.05.2024)
- Celebrating Clinical Trials Day: Highlighting the Outside-the-Box Studies that Push the Boundaries (20.05.2024)
- Revolutionizing the landscape for small-cap, development-stage life science companies. (20.05.2024)
- Meet Vlad Bogin at ASCO 2024 (27.05.2024)
- Meet us at the BIO International Convention 2024 (30.05.2024)
- We are at the BIO International Convention 2024 (06.06.2024)
- Clinical Research Focus. 29th Edition (11.06.2024)
- Cromos Pharma's No Patients - No Payment™ program explained (11.06.2024)
- Cromos Pharma’s Agnieszka Milewska-Kranc Leads the Way in EU’s Rare Disease Advocacy (12.06.2024)
- Key Takeaways From The 2024 ASCO Annual Meeting (13.06.2024)
- FDA's Comprehensive New Guidelines Impacting Clinical Trials and Gene Therapy (18.06.2024)
- Digital Twins in Clinical Research: Revolutionizing Study Design (20.06.2024)
- Successful Partnership Between MAIA Biotechnology and Cromos Pharma (24.06.2024)
- CEO Insights Podcast: Interview with Vlad Bogin (27.06.2024)
- Major Enhancements Set to Transform Clinical Trial Practices with ICH GCP E6 R3 (02.07.2024)
- Clinical Research Focus. 30th Edition (09.07.2024)
- PMBoK, ISO 9001, and ICH GCP: Three Pillars of Quality in Clinical Research (16.07.2024)
- Expanding Horizons: "Syngene - Cromos Pharma" Alliance Transforms Clinical Research (18.07.2024)
- Unleashing Biotech Success: Why Smaller CROs Are the Key to Big Wins (23.07.2024)
- Cromos Pharma’s Türkiye Country Head Speaks at Biruni University Event in Istanbul (01.08.2024)
- Meet Vlad Bogin at Morgan Stanley 22nd Annual Global Healthcare Conference 2024 (06.08.2024)
- Revolutionary HIV Breakthrough: Is Lenacapavir the Ultimate Game-Changer? (08.08.2024)
- Clinical Research Focus. 31st Edition (13.08.2024)
- Poland: Europe’s New Hub for Clinical Research (20.08.2024)
- New Research Alert: Alarming Trends in Men’s Cancer Incidence & Projections to 2050 (22.08.2024)
- New Study Raises Concerns Over Ozempic’s Potential Link to Suicidal Thoughts (03.09.2024)
- Clinical Research Focus. 32nd Edition (05.09.2024)
- Vlad Bogin at the Morgan Stanley 22nd Annual Global Healthcare Conference (11.09.2024)
- 7 Reasons to Choose Central and Eastern Europe as Your Go-To Destination for Clinical Trials (12.09.2024)
- New Cromos Pharma's Office in Portugal (17.09.2024)
- Exploring Portugal's Clinical Trials Landscape: Innovations, Infrastructure, and Opportunities (19.09.2024)
- Cromos Pharma’s Monika David Shares Key Insights at Hungarian Clinical Trials Conference (25.09.2024)
- How AI is Revolutionizing Heart Health: 7 Breakthroughs to Watch This World Heart Day (27.09.2024)
- Clinical Research Focus. 33rd Edition (01.10.2024)
- Celebrating 20 Years of Success with Cromos Pharma (03.10.2024)
- World Mental Health Day: How Clinical Trials are Transforming Mental Health Treatments for the Future (10.10.2024)
- Mastering EU Regulatory Compliance: Key Roles of the LR, DPO, and DPR in Clinical Trials (Part 1) (15.10.2024)
- GDPR Essentials: What You Need to Know About Appointing a Data Protection Officer (17.10.2024)
- Do You Need a Data Protection Representative? Understanding GDPR's Article 27 Requirement (22.10.2024)
- Cromos Pharma's 20th Anniversary (25.10.2024)
- How the EU CTR is Shaping the Future of Clinical Trials: Insights and Key Challenges for Sponsors (29.10.2024)
- Groundbreaking Stem Cell Therapy Offers New Hope for Type 1 Diabetes: A Medical Breakthrough (05.11.2024)
- Changing Defibrillator Pad Placement Increases Survival by 164% (07.11.2024)
- Clinical Research Focus. 34th Edition (13.11.2024)
- World Diabetes Day Focus: The Role of GLP-1 Agonists and SGLT2 Inhibitors in Diabetes Treatment (14.11.2024)
- Advancing Lung Cancer Care: New Treatment Insights Highlighted During Awareness Month (19.11.2024)
- AI in Clinical Trials: 8 Groundbreaking Innovations That Defined the Year (26.11.2024)
- Countdown to ASH 2024: What to Expect in Breakthroughs in Hematology-Oncology (02.12.2024)
- Clinical Research Focus. 35th Edition (05.12.2024)
- Exploring Türkiye’s Edge in Clinical Research: Insights into Hospital Systems and Regulatory Framework (13.12.2024)
- Reflections on ASH 2024: Transformative Breakthroughs in Hematology-Oncology (18.12.2024)
- 12 Medical Breakthroughs That Seemed Impossible (19.12.2024)
- 2024’s Top 12 Clinical Trials: Transforming the Future of Medicine (23.12.2024)
- The Most Impactful FDA Drug Approvals of 2024: A Transformative Year for Biopharma (30.12.2024)
- Happy New Year 2025 (31.12.2024)
- Meet Vlad Bogin at the 43rd Annual J.P. Morgan Healthcare Conference 2025 (06.01.2025)
- Clinical Research Focus. 36th Edition (07.01.2025)
- Serbia is a Rising Star in Clinical Research (14.01.2025)
- Reflections from JPM 2025: A CEO’s Perspective on Biopharma’s New Era (21.01.2025)
- The Optimus Revolution: Four Years of Progress in Oncology Drug Development (23.01.2025)
- Choosing the Right Endpoints in Oncology Trials (29.01.2025)
- World Cancer Day 2025: How Clinical Trials Are Shaping the Future of Cancer Treatment (04.02.2025)
- Meet Cromos Pharma at the Texas BioLife Summit 2025 (07.02.2025)
- Clinical Research Focus. 37th Edition (11.02.2025)
- Key Takeaways from SCOPE 2025: Insights from Cromos Pharma's US Business Development Director (13.02.2025)
- Bulgaria: A Rising Hub for Clinical Research in Europe (25.02.2025)
- Regulatory Pathways for Rare Disease Drug Development: What Sponsors Need to Know – Rare Disease Day Special (27.02.2025)
- Meet Us at the IO360° Summit 2025 (03.03.2025)
- Clinical Research Focus. 38th Edition (04.03.2025)
- Diversity in Clinical Trials: The Path Forward Amid Uncertainty (11.03.2025)
- World Kidney Day: Top 7 Breakthroughs in Kidney Disease Treatment (13.03.2025)
- Meet Cromos Pharma at the CMO Summit 360° (18.03.2025)
- The European Health Data Space (EHDS): A Game Changer for Clinical Research and Pharma? (25.03.2025)
- Clinical Research Focus. 39th Edition (02.04.2025)
- FDA vs. EMA: Navigating Divergent Regulatory Expectations for Cell and Gene Therapies. What Biopharma Companies Need to Know (03.04.2025)
- Our New Country Head for Türkiye (09.04.2025)
- Engaging Early with EMA Scientific Advice: A Strategic Advantage for Sponsors (15.04.2025)
- Hatch-Waxman: The Underrated Power Tool in the Biotech Playbook (22.04.2025)
- CT Scans and Future Cancer Risk: Time to Recalibrate How We Use Imaging (24.04.2025)
- Meet Us at the ASCO Annual Meeting 2025 (01.05.2025)
- World Asthma Day 2025: A New Era in Respiratory Care (06.05.2025)
- Clinical Research Focus. 40th Edition (13.05.2025)
- Meet Us at BIO 2025 (16.05.2025)
- Progress with Heart: Honoring Every Patient’s Journey (19.05.2025)
- Clinical Trials Day 2025 (20.05.2025)
- CTIS Webinar in the Works – We Need Your Input! (22.05.2025)
- Post-ASCO 2025 Insights: What Oncology Sponsors Need To Know (05.06.2025)
- Clinical Research Focus. 41st Edition (12.06.2025)
- Rescuing Failing Cancer Trials with the Right Oncology CRO (18.06.2025)
- 5 Steps to Successful Patient Recruitment in Clinical Trials (25.06.2025)
- Key Takeaways from BIO 2025: What’s Next for Biotech and Clinical Trials (01.07.2025)
- Clinical Research Focus. 42nd Edition (08.07.2025)
- Clinical Trial Rescue: How to Spot Trouble and Act Fast (24.07.2025)
- Sarepta Pauses Elevidys Shipments After Three Patient Deaths Linked to Gene Therapy (29.07.2025)
- Clinical Research Focus. 43rd Edition (05.08.2025)
- Project Manager (10.08.2025)
- MILESTONE ACHIEVED: Cromos Pharma Earns ISO 9001:2015 Certification When compliance becomes a competitive advantage (13.08.2025)
- Global Oncology Trials, Local Relevance: Why the FDA Just Raised the Bar (14.08.2025)
- Meet Nicole Brenna at Morgan Stanley 23rd Annual Global Healthcare Conference 2025 (18.08.2025)
- From Tariff-Free to Targeted: How the EU–US Trade Deal Puts Pharma in the Crosshairs (26.08.2025)
- From Confusion to Confidence: Mastering EU CTR/CTIS Webinar (03.09.2025)
- Clinical Research Focus. 44th Edition (09.09.2025)
- ISO 9001:2015 and ICH GCP E6(R3): Two Standards, One Language of Quality in Clinical Research (16.09.2025)
- Mastering CTIS Webinar (24.09.2025)
- Mastering CTIS: Strategies for Multi-Country Submissions, Compliance & Operational Success (25.09.2025)
- Business Development Assistant (02.10.2025)
- Clinical Research Focus. 45th Edition (02.10.2025)
- From Numbers to Meaning — Sensitivity, Specificity & Predictive Value (14.10.2025)
- CRO Regulatory Affairs: Bridging Strategy, Compliance, and Speed (21.10.2025)
- From Oysters to Orthopedics: China’s “Bone-02” Bio-Glue Redefines Fracture Repair (22.10.2025)
- ESMO 2025: Notes From the Floor — What Will Really Change Oncology in 2026 (28.10.2025)
- Clinical Research Focus. 46th Edition (11.11.2025)
- Five Insights Changing Alzheimer’s Care in 2025 (13.11.2025)
- Cancer Vaccines 2025, Part I: The mRNA Revolution (24.11.2025)
- Lecture at the IX Student Pharma Forum organized by BPhSA (28.11.2025)
- Cancer Vaccines 2025, Part II: The Rise of DNA Cancer Vaccines (09.12.2025)
- Clinical Research Focus. 47th Edition (11.12.2025)
- Happy Hanukkah! (12.12.2025)
- Infectious Disease CRO: Expertise, Services, and Capabilities for Clinical Trials (15.12.2025)
- 12 Stories of Courage and Cure: A Holiday Message from Cromos Pharma (18.12.2025)
- Meet us at the J.P. Morgan Healthcare Conference (18.12.2025)
- The Most Transformative FDA Approvals of 2025: Therapies Redefining Clinical Research and Future Trial Strategy (22.12.2025)
- Happy New Year 2026! (29.12.2025)
- Clinical Research Focus. 48th Edition (07.01.2026)
- 2025’s Top Clinical Trials: Closing a Transformative Year in Medicine (15.01.2026)
- Neurology CRO: Key Challenges in CNS Clinical Trials (17.01.2026)
- Martin Luther King Jr. Day (19.01.2026)
- Our New Regional Clinical Manager Europe (20.01.2026)
- Clinical Research in 2026: What Changed — and Why It Matters (22.01.2026)
- After JPM 2026: Where Healthcare Strategy Is Actually Heading (28.01.2026)
- Clinical Research Focus. 49th Edition (02.02.2026)
- World Cancer Day 2026: What Cancer Vaccines Have Already Achieved in Real Clinical Practice (04.02.2026)
- Why SCOPE 2026 Felt Different for Clinical Research (10.02.2026)
- Oncology CRO: A Practical RFP Guide for Sponsors and Biotech Teams (12.02.2026)
- FDA Rejects Regenxbio’s Hunter Syndrome Gene Therapy: A Turning Point for the AAV Field? (19.02.2026)
- FDA Signals Shift Toward a One-Trial Default for Drug Approval (23.02.2026)
- Rare Disease Day 2026: A New Economic Reality for Pharma (26.02.2026)
- Clinical Trial Budget Calculator by Cromos Pharma (03.03.2026)
- AI-Powered Clinical Trial Budget Calculator (03.03.2026)
- Clinical Research Focus. 50th Edition (05.03.2026)
- World Kidney Day 2026 | What Sponsors Should Know About the Future of Kidney Trials (12.03.2026)
- Oncology CRO: How to Choose the Right Partner for Clinical Trials (16.03.2026)
- Happy St. Patrick’s Day 2026 (17.03.2026)
- Meet Nicole Brenna at the AACR Annual Meeting (18.03.2026)
- Rare Disease CRO Services | Cromos Pharma (18.03.2026)
- FDA Signals Shift in Regulatory Approach to Autoimmune CAR-T (26.03.2026)
- Clinical Research Focus. 51st Edition (07.04.2026)
- Cagla Akmemis Was Invited as a Speaker (09.04.2026)
- A Breakthrough in One of the Deadliest Cancers? What Daraxonrasib Really Changes (21.04.2026)
- FDA Flags 2,200+ Sponsors Over Missing Trial Results (23.04.2026)
- Full Service CRO vs FSP: Which Model Is Better? (24.04.2026)
- From Data to Decisions: Lessons from 10+ Years in Clinical Biometrics (30.04.2026)
- Clinical Research Focus. 52nd Edition (07.05.2026)
- The US–UK Pharma Deal Is Bigger Than It Looks (12.05.2026)
- World Clinical Trials Day: Clinical Research Is Not Where It Used to Be (20.05.2026)
- Meet Vlad Bogin at the ASCO Annual Meeting 2026 (21.05.2026)
- Memorial Day 2026 (25.05.2026)
- Meet Nicole Brenna at the BIO International Convention 2026 (26.05.2026)
- CRO in Poland: Why Poland Is Becoming a Core Country for Oncology Clinical Trials in Europe (27.05.2026)
- FDA, AI, and the Future of Clinical Trials (28.05.2026)
- Greetings from ASCO 2026 (01.06.2026)
- FSP Model in Clinical Research: Everything Sponsors Need to Know (02.06.2026)
- Clinical Research Focus. 53rd Edition (03.06.2026)
- ASCO 2026: Five Trends That Caught My Attention (04.06.2026)
- The Endpoint Bubble: Why Clinical Trials Are Drowning in Measurements That Don’t Matter (11.06.2026)
- Full Service CRO: Benefits, Costs, and How to Choose the Right Partner (14.06.2026)
- The International Clinical Trials Day Event (18.06.2026)
- Greetings from BIO 2026 (24.06.2026)
- Senior Clinical Research Associate (25.06.2026)
- CRO Clinical Trial Execution: What a CRO Does Across Phases, Costs, and Where Sponsors Go Wrong (27.06.2026)
- How to Choose a CRO for Phase 1 and Phase 2 Clinical Trials (30.06.2026)
- Happy Independence Day 2026 (03.07.2026)
- BIO 2026: Five Industry Shifts That Will Shape Clinical Development Over the Next Few Years (08.07.2026)
- Clinical Research Focus. 54th Edition (13.07.2026)
- Our new Global Head of Quality & Compliance (14.07.2026)
- The $137 Billion Wake-Up Call: What Operation TrialBlazer Really Changes for Sponsors (21.07.2026)
- In-house CRA (23.07.2026)
- World Lung Cancer Day: Four Breakthroughs Worth Watching in 2026 (31.07.2026)
- Clinical Research Focus. 55th Edition (04.08.2026)
- The Next GLP-1 Moment? Why Big Pharma Is Investing in Depression (13.08.2026)
- Big Pharma is betting billions on vaccines. Washington is making that bet harder to win. (20.08.2026)
- Cromos Pharma Regulatory Radar | 2026 Mid-Year Update (27.08.2026)
- Clinical Research Focus. 56th Edition (02.09.2026)
- Rejected Twice, Then Approved: What Replimune’s FDA Reversal Means for Drug Developers (08.09.2026)
- Senior Clinical Research Associate (15.09.2026)
- Rare Disease Recruitment Is Getting Harder. Is Türkiye Being Overlooked? (15.09.2026)
- World Alzheimer’s Day 2026: Is Clinical Research Ready for the Next Era of Alzheimer’s Trials? (22.09.2026)
- China Built an AI-Agent Eye Clinic. Here Is What Happened in the Real World (24.09.2026)
- The Obesity Drug Race: Who Can Challenge Lilly and Novo? (29.09.2026)
- Head of Project Management (30.09.2026)
- Clinical Research Focus. 57th Edition (06.10.2026)
- State of Biopharma R&D 2026: 7 Numbers Every Sponsor Should Know (08.10.2026)
- AI, Quality, and Accountability: Six Questions Every Quality Leader Should Ask (19.10.2026)
- Meet Vlad Bogin at the ESMO Congress 2026 (21.10.2026)
- Are We Getting Closer to a Functional Cure for Type 1 Diabetes? (21.10.2026)
- How to Choose a Dermatology CRO: 7 Critical Questions for Clinical Trial Sponsors (21.10.2026)
- Greetings from ESMO Congress 2026 in Madrid (26.10.2026)
- Clinical Trials in Italy: A 2026 Guide to Patient Recruitment, Regulatory Approval, and Study Start-Up (28.10.2026)
- ESMO 2026: Six Advances Reshaping Oncology and Clinical Development (02.11.2026)
- Clinical Research Focus. 58th Edition (05.11.2026)
- Patient-Centric Feasibility: When Protocol Meets Patient Reality (09.11.2026)
- Meet Vlad Bogin at the ASH Annual Meeting 2026 (11.11.2026)
- World Diabetes Day 2026: Six Breakthroughs Redefining Diabetes Treatment (12.11.2026)
- Information Technologies Specialist (20.11.2026)
Pages
Сountries
- Poland (15.11.2022)
- Czech Republic (15.11.2022)
- Ukraine (07.12.2022)
- Türkiye (08.12.2022)
- Kazakhstan (08.12.2022)
- Serbia (09.12.2022)
- Georgia (09.12.2022)
- Hungary (09.12.2022)
- United States (09.12.2022)
- Moldova (26.01.2023)
- Croatia (26.01.2023)
- Lithuania (26.01.2023)
- Estonia (26.01.2023)
- Romania (26.01.2023)
- Slovenia (26.01.2023)
- Latvia (26.01.2023)
- The Slovak Republic (26.01.2023)
- Bulgaria (26.01.2023)
- Portugal (16.09.2024)
- France (19.02.2026)
- Germany (19.02.2026)
- Italy (29.10.2026)
Therapeutic
- Oncology (27.03.2023)
- Cardiology (27.03.2023)
- Ophthalmology (27.03.2023)
- Neurology (27.03.2023)
- Endocrinology (27.03.2023)
- Gastroenterology (27.03.2023)
- Dermatology (27.03.2023)
- Urology (27.03.2023)
- Infectious diseases (including Covid-19) (27.03.2023)
- Psychiatry (27.03.2023)
- Rare and Orphan Diseases (27.03.2023)
Conferences
- World Orphan Drug Congress USA 2023 (05.05.2023)
- 12th Clinical Trials Strategic Summit (05.05.2023)
- The 2023 ASCO Annual Meeting (07.05.2023)
- BIO International Convention (07.05.2023)
- The 17th Clinical Trials Nexus Conference (07.05.2023)
- Clinical Operations In Oncology Trials East Coast 2023 (03.07.2023)
- Global Site Solutions Summit (11.09.2023)
- 18th BioPharma Clinical Trials Nexus Conference (11.09.2023)
- ESMO 2023 Congress (11.09.2023)
- CPHI 2023 Barcelona (11.09.2023)
- SITC 38th Annual Meeting 2023 (26.09.2023)
- 65th ASH Annual Meeting and Exposition (09.10.2023)
- 42nd Annual J.P. Morgan Healthcare Conference (01.11.2023)
- SCOPE Summit 2024 (12.12.2023)
- Texas BioLife Summit 2024 (29.01.2024)
- AACR Annual Meeting 2024 (09.02.2024)
- Global Oncology Site Solution Summit (09.02.2024)
- BioNJ’s 2024 Biopartnering Conference (24.04.2024)
- ASCO Annual Meeting 2024 (24.04.2024)
- BIO international convention 2024 (24.04.2024)
- Morgan Stanley 22nd Annual Global Healthcare Conference 2024 (30.07.2024)
- The 66th ASH Annual Meeting and Exposition 2024 (16.10.2024)
- 43rd Annual J.P. Morgan Healthcare Conference (19.11.2024)
- SCOPE Summit 2025 (19.11.2024)
- Immuno-Oncology 360° Summit 2025 (07.02.2025)
- Chief Medical Officer Summit 360º 2025 (07.02.2025)
- ASCO Annual Meeting 2025 (11.02.2025)
- BIO international convention 2025 (11.02.2025)
- Morgan Stanley 23rd Annual Global Healthcare Conference 2025 (15.08.2025)
- ESMO Congress 2025 (08.09.2025)
- The 67th ASH Annual Meeting and Exposition 2025 (08.09.2025)
- 44th Annual J.P. Morgan Healthcare Conference (08.12.2025)
- SCOPE Summit 2026 (08.12.2025)
- AACR Annual Meeting 2026 (06.02.2026)
- ASCO Annual Meeting 2026 (06.02.2026)
- BIO international convention 2026 (06.02.2026)
- ESMO Congress 2026 (14.09.2026)
- ASH Annual Meeting 2026 (25.09.2026)